|
HY-112616-10mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
|
HY-112616-100mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
|
HY-112616-25mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
|
HY-112616-5mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
|
HY-112616-50mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
|
HY-I0678-1mg
|
MedChemexpress LLC
|
Regoraf�nib N-oxyde (M2) [CAS 835621-11-9]
|
|
Cancer-programmed cell death
|
|
|
HY-I0678-10mg
|
MedChemexpress LLC
|
Regoraf�nib N-oxyde (M2) [CAS 835621-11-9]
|
|
Cancer-programmed cell death
|
|
|
HY-I0678-5mg
|
MedChemexpress LLC
|
Regoraf�nib N-oxyde (M2) [CAS 835621-11-9]
|
|
Cancer-programmed cell death
|
|
|
HY-I0678-1mL
|
MedChemexpress LLC
|
Regoraf�nib N-oxyde (M2) [CAS 835621-11-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-123450-10mg
|
MedChemexpress LLC
|
S116836 [CAS 1257628-57-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-123450-100mg
|
MedChemexpress LLC
|
S116836 [CAS 1257628-57-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-123450-25mg
|
MedChemexpress LLC
|
S116836 [CAS 1257628-57-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-123450-5mg
|
MedChemexpress LLC
|
S116836 [CAS 1257628-57-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-123450-50mg
|
MedChemexpress LLC
|
S116836 [CAS 1257628-57-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-136201-1g
|
MedChemexpress LLC
|
Sodium Glucoheptonate [CAS 31138-65-5]
|
|
Cancer-programmed cell death
|
|
|
HY-136201-5g
|
MedChemexpress LLC
|
Sodium Glucoheptonate [CAS 31138-65-5]
|
|
Cancer-programmed cell death
|
|
|
HY-10330A-10mg
|
MedChemexpress LLC
|
Toceranib (phosphate) [CAS 874819-74-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-10330A-100mg
|
MedChemexpress LLC
|
Toceranib (phosphate) [CAS 874819-74-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-10330A-25mg
|
MedChemexpress LLC
|
Toceranib (phosphate) [CAS 874819-74-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-10330A-5mg
|
MedChemexpress LLC
|
Toceranib (phosphate) [CAS 874819-74-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-10330A-50mg
|
MedChemexpress LLC
|
Toceranib (phosphate) [CAS 874819-74-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-10330-10mg
|
MedChemexpress LLC
|
Toceranib [CAS 356068-94-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10330-5mg
|
MedChemexpress LLC
|
Toceranib [CAS 356068-94-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10330-50mg
|
MedChemexpress LLC
|
Toceranib [CAS 356068-94-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-13894-1mg
|
MedChemexpress LLC
|
Tyrphostin AG1296 [CAS 146535-11-7]
|
|
COVID-19-immunoregulation
|
|
